Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:awardReceived |
gptkb:Biotechnology_Heritage_Award
gptkb:American_Chemical_Society_Heroes_of_Chemistry_Award |
| gptkbp:birthDate |
1951-05-07
|
| gptkbp:birthPlace |
gptkb:United_States
|
| gptkbp:causeOfDeath |
unknown (not publicly disclosed)
|
| gptkbp:deathDate |
2021-03-30
|
| gptkbp:education |
gptkb:Georgia_Institute_of_Technology
gptkb:University_of_Chicago gptkb:University_of_Colorado_Boulder |
| gptkbp:employer |
gptkb:Gilead_Sciences
|
| gptkbp:fieldOfWork |
HIV/AIDS research
pharmaceutical industry |
| https://www.w3.org/2000/01/rdf-schema#label |
John C. Martin
|
| gptkbp:knownFor |
CEO of Gilead Sciences
|
| gptkbp:nationality |
gptkb:American
|
| gptkbp:notableWork |
HIV/AIDS treatment innovation
development of antiviral drugs |
| gptkbp:occupation |
gptkb:business_executive
chemist |
| gptkbp:positionHeld |
CEO
|
| gptkbp:bfsParent |
gptkb:Gilead_Sciences,_Inc.
|
| gptkbp:bfsLayer |
6
|